Darren Karasiuk - Flowr Corp CEO Director
Insider
Darren Karasiuk is CEO Director of Flowr Corp
| Age | 51 |
| Phone | 905 940 3993 |
| Web | https://www.flowr.ca |
Flowr Corp Management Efficiency
The company has return on total asset (ROA) of (0.1644) % which means that it has lost $0.1644 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5878) %, meaning that it generated substantial loss on money invested by shareholders. Flowr Corp's management efficiency ratios could be used to measure how well Flowr Corp manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Baldyga | Biofrontera | N/A | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| Eugene III | Biofrontera | 39 | |
| Thomas Flow | Akanda Corp | 46 | |
| David Erickson | Evolus Inc | N/A | |
| Matthew Coapman | cbdMD Inc | 48 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Raymond Coffman | cbdMD Inc | 62 | |
| BComm BCom | Akanda Corp | 68 | |
| Rami Levy | INC Research Holdings | 59 | |
| Amos Cohen | INC Research Holdings | 45 | |
| Sandra Beaver | Evolus Inc | 46 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| John Weston | cbdMD Inc | N/A | |
| BCom BAcc | Akanda Corp | 44 | |
| Jeff Holm | Biofrontera | N/A | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
Management Performance
| Return On Equity | -1.59 | |||
| Return On Asset | -0.16 |
Flowr Corp Leadership Team
Elected by the shareholders, the Flowr Corp's board of directors comprises two types of representatives: Flowr Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Flowr. The board's role is to monitor Flowr Corp's management team and ensure that shareholders' interests are well served. Flowr Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Flowr Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ivan Latysh, Chief Officer | ||
| Thierry Elmaleh, Head Markets | ||
| David Aronowitz, Chief Staff | ||
| Steven Klein, CoFounder Strategist | ||
| Pauric Duffy, Managing Europe | ||
| Peter Comerford, Managing AsiaPacific | ||
| Darren Karasiuk, CEO Director | ||
| Sean Griffin, VP PR |
Flowr Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Flowr Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.59 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (1.97) % | |||
| Current Valuation | 13.79 M | |||
| Shares Outstanding | 426.47 M | |||
| Shares Owned By Insiders | 29.86 % | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 0.65 X | |||
| Revenue | 12.35 M | |||
| Gross Profit | (9.66 M) |
Currently Active Assets on Macroaxis
Other Information on Investing in Flowr Pink Sheet
Flowr Corp financial ratios help investors to determine whether Flowr Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Flowr with respect to the benefits of owning Flowr Corp security.